- Efficacy of regorafenib in the treatment of advanced hepatoc... 2026-01-12
- Efficacy and safety of immune checkpoint inhibitors plus che... 2026-01-12
- Advances in radiofrequency ablation for pancreatic cancer 2026-01-12
- Revisiting multi-region 16S sequencing in gastric cancer 2026-01-12
- Molecular mosaic of colorectal cancer: Why one classificatio... 2026-01-12
World Journal of Gastrointestinal Oncology (WJGO, World J Gastrointest Oncol) is a high-quality, open-access academic journal that employs a single-blind peer-review process. The journal focuses on publishing clinical, basic, and translational research achievements that are innovative, novel, and practical in the fields of gastrointestinal oncology. The types of articles published in WJGO include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. All submissions must comply with academic norms and ethical requirements. WJGO is edited and published by the Baishideng Publishing Group. Submit here >>
- Winnie Yeo, FRCP, FRCPE, MD, Professor, (E-mail: winnie@clo.cuhk.edu.hk) Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, China
The 2025 edition of Journal Citation Reports® cites the 2024 journal impact factor (JIF) for WJGO as 2.5; JIF without journal self cites: 2.4; 5-year JIF: 2.7; JIF Rank: 68/147 in gastroenterology and hepatology; JIF Quartile: Q2; and 5-year JIF Quartile: Q3; JIF Rank: 188/326 in oncology; JIF Quartile: Q3; and 5-year JIF Quartile: Q3.
The WJGO’s CiteScore for 2024 is 3.3 and Scopus CiteScore rank 2024: Gastroenterology is 89/173; Oncology is 235/415.





